Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.54
+0.21 (3.94%)
Mar 9, 2026, 1:17 PM EDT - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $357.72 million as of March 9, 2026. Its market cap has increased by 573.72% in one year.
Market Cap
357.72M
Enterprise Value
196.46M
1-Year Change
573.72%
Ranking
Category
Stock Price
$5.54
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $357.72M, a decrease of -2.22%. That is a compound annual growth rate of -0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 344.16M | -19.00% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 361.84M |
| Bicycle Therapeutics | 360.71M |
| Absci | 357.88M |
| Aura Biosciences | 355.62M |
| Neurogene | 343.41M |
| Climb Bio | 342.97M |
| Foghorn Therapeutics | 338.60M |
| Opus Genetics | 337.23M |